首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:International journal of surgical pathology

缩写:INT J SURG PATHOL

ISSN:1066-8969

e-ISSN:1940-2465

IF/分区:1.0/Q3

文章目录 更多期刊信息

共收录本刊相关文章索引2845
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Sofia Canete-Portillo,Antonio L Cubilla,George J Netto et al. Sofia Canete-Portillo et al.
Background: This study investigates the interplay between PD-L1, FOXP3+ regulatory T cells, and CD8+ cytotoxic T lymphocytes in penile squamous cell carcinoma (penile SCC), where understanding the tumor immune microenvironment is crucial. M...
Claudia Grosse,Alexandra Grosse Claudia Grosse
Anaplastic lymphoma kinase (ALK)-rearranged myxoid spindle cell tumors represent a recently recognized subgroup of kinase fusion-positive mesenchymal neoplasms. These tumors often arise in the superficial soft tissues but may occasionally b...
Hania Fatima,Sahar Suleman,Syeda Maria Ahmad Zaidi et al. Hania Fatima et al.
Nodular fasciitis is a benign, self-limiting, and rapidly proliferating fibroblastic/myofibroblastic lesion. Nodular fasciitis, in the head and neck region, in particular, poses significant diagnostic challenges due to its rapid growth and ...
Neha Bakshi,Bheem Nanda,Seema Rao et al. Neha Bakshi et al.
IntroductionTransgender men are assigned female sex at birth, but identify with a masculine gender identity, prompting them to undergo gender-affirming surgery, usually following androgen therapy, which induces changes in histology of hormo...
Alireza Abdollahi,Emad Mehrtash,Bita Jafarzadeh et al. Alireza Abdollahi et al.
Background and AimsProgrammed death-ligand 1 (PD-L1) is an immune checkpoint molecule with proven therapeutic and prognostic implications. However, its prognostic significance in skin neoplasms remains controversial. In this study, we aimed...
Jessica Alvarez-Lesmes,Andrew Rosenberg,Daniel P Cassidy Jessica Alvarez-Lesmes
Rosai-Dorfman disease is an uncommon histiocytic neoplasm that is often self-limiting; however, rarely, it exhibits aggressive behavior and may undergo biological transformation to histiocytic sarcoma. Pathogenic genetic drivers of Rosai-Do...
Rasheeda Mohamedali,Aishwarya Sharma,Deepander Rathore et al. Rasheeda Mohamedali et al.
SMARCB1/INI1 (integrase interactor 1) deficient undifferentiated carcinomas of the gastrointestinal tract are highly aggressive neoplasms with a poor clinical outcome. Due to their rarity, the clinicopathological characteristics and molecul...
Sameer Chhetri Aryal,Natalie Banet Sameer Chhetri Aryal
Introduction: Selected patients with pelvic high-grade serous carcinoma (HGSC) receive neoadjuvant chemotherapy prior to resection. Guidelines allow cytopathology fluids to be used to confirm this diagnosis before neoadjuvant chemotherapy, ...
Carol N Rizkalla,Maria Tretiakova,Sean R Williamson et al. Carol N Rizkalla et al.
Osteoclast-rich undifferentiated carcinoma of the urinary tract, herein referred to as urothelial carcinoma with osteoclast-like giant cells (UCOGC), is an uncommon tumor currently classified under "poorly differentiated" urothelial carcino...
Xu Liu,Jiao Liu,Jingwen Hu et al. Xu Liu et al.
Succinate dehydrogenase (SDH)-deficient renal cell carcinoma (RCC) is a rare molecularly defined renal tumor characterized by defects in the subunit types SDHA, SDHB, SDHC, and SDHD, with most of these genetic alterations involving the SDHB...